Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy DBV Technologies stock

Learn how to easily invest in DBV Technologies stock.

DBV Technologies is a biotechnology business based in the US. DBV Technologies shares (DBVT) are listed on the NASDAQ and all prices are listed in US Dollars. DBV Technologies employs 88 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in DBV Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DBVT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

DBV Technologies stock price (NASDAQ: DBVT)

Use our graph to track the performance of DBVT stocks over time.

DBV Technologies shares at a glance

Information last updated 2022-07-01.
Latest market close$2.39
52-week range$1.15 - $5.99
50-day moving average $1.71
200-day moving average $2.37
Wall St. target price$5.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.77

Buy DBV Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy DBV Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DBV Technologies price performance over time

Historical closes compared with the close of $2.39 from 2022-07-01

1 week (2022-06-27) -1.65%
1 month (2022-06-03) 51.27%
3 months (2022-04-04) 42.26%
6 months (2022-01-04) 35.80%
1 year (2021-07-02) -58.00%
2 years (2020-07-02) -46.53%
3 years (2019-07-03) 9.44
5 years (2017-07-03) 35.57

DBV Technologies financials

Revenue TTM $5.3 million
Gross profit TTM $5.7 million
Return on assets TTM -31.96%
Return on equity TTM -67.72%
Profit margin 0%
Book value $0.75
Market capitalisation $478.6 million

TTM: trailing 12 months

DBV Technologies share dividends

We're not expecting DBV Technologies to pay a dividend over the next 12 months.

DBV Technologies share price volatility

Over the last 12 months, DBV Technologies's shares have ranged in value from as little as $1.15 up to $5.99. A popular way to gauge a stock's volatility is its "beta".

DBVT.US volatility(beta: 2.08)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DBV Technologies's is 2.0775. This would suggest that DBV Technologies's shares are significantly more volatile than the average for this exchange and represent a higher risk.

DBV Technologies overview

DBV Technologies S. A. , a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers.

Frequently asked questions

What percentage of DBV Technologies is owned by insiders or institutions?
Currently 0.396% of DBV Technologies shares are held by insiders and 11.892% by institutions.
How many people work for DBV Technologies?
Latest data suggests 88 work at DBV Technologies.
When does the fiscal year end for DBV Technologies?
DBV Technologies's fiscal year ends in December.
Where is DBV Technologies based?
DBV Technologies's address is: 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120
What is DBV Technologies's ISIN number?
DBV Technologies's international securities identification number is: US23306J1016
What is DBV Technologies's CUSIP number?
DBV Technologies's Committee on Uniform Securities Identification Procedures number is: 23306J101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site